| I |
|
Identification and characterisation of new immunoreactive proteins of Chlamydia trachomatis
|
| Forsbach-Birk V., Pfrepper K.-I., Simnacher U., Soutschek E., Essig A. |
| |
|
Identification and genotyping of uropathogenic Escherichia coli strains isolated from patients with urinary tract infection based on papC and papG genes using PCR
|
| Zamanzad B. |
| |
|
Identification and susceptibility testing of Enterococcus casseliflavus and Enterococcus gallinarum by Phoenix 100 system (Becton Dickinson)
|
| Chatzigeorgiou K.-S., Tarpatzi A., Siafakas N., Pantelaki M., Charalampaki N., Zerva L. |
| |
|
Identification of Candida species by restriction enzyme analysis
|
| Yis R., Yücesoy M. |
| |
|
Identification of Leishmania species isolated from human cutaneous leishmaniasis in Gonbad-e Qabus using a PCR method
|
| Mesgarian F., Rahbarian N., Mahmoudi Rad M., Hajaran H., Shahbazi F., Mesgarian Z., Taghipour N. |
| |
|
Identification of Mycobacterium tuberculosis-specific CD4 and CD8 IFN-gamma and/or IL-2 secreting cells by a novel method contributes to defining the different stages of tuberculosis
|
| Sargentini V., Mariotti S., Carrara S., Gagliardi M.C., Teloni R., Goletti D., Nisini R. |
| |
|
Identification of Paracoccidioides brasiliensis highly virulent isolate ligands peptides by phage display with fungicidal activity in vitro
|
| Kioshima E.S., Aliperti F., Villa L.L., Lopes J.D. |
| |
|
Identification of a "hot spot" for integration of mobile elements in Enterococcus faecium
|
| Top J., van Schaik W., Bonten M., Willems R. |
| |
|
Identification of a Staphylococcus aureus strain with increased intracellular growth and reduced intracellular susceptibility to gentamicin
|
| Olivier A., Van Bambeke F., Mingeot-Leclercq M.P., Tulkens P.M. |
| |
|
Identification of a novel genomic island specific for Enterococcus faecium CC17 by using the deltarho-Web model
|
| Heikens E., Leavis H.L., van Schaik W., Bonten M.J.M., Willems R.J.L. |
| |
|
Identification of a novel group 1 coronavirus from Chinese horseshoe bats
|
| Lam C.S.F., Lau S.K.P., Woo P.C.Y., Li K.S.M., Huang Y., Wang M., Xu H., Guo R., Chan K.H., Zheng B.J., Yuen K.Y. |
| |
|
Identification of an OXA-58 carbapenemase in an unusual Portuguese Acinetobacter baumannii clinical isolate
|
| Caneiras C., Ferreira T., Duarte A., da Silva G. |
| |
|
Identification of enterococcal plasmids by multiplex-PCR-based relaxase typing
|
| Goicoechea P., Romo M., Coque T.M., Baquero F., de la Cruz F., Martínez-Martínez L., Francia M.V. |
| |
|
Identification of mutations in HERG and KCNE2 genes associated with arrhythmia in patients treated with macrolides
|
| Pannacci M., Caronno A., Lucini V., Grosso S., Scaglione F. |
| |
|
Identification of mycobacteria by Raman spectroscopy
|
| Willemse-Erix H.F.M., Buijtels P.C.A.M., Petit P.L.C., Endtz H.Ph., Puppels G.J., Verbrugh H.A., Maquelin K., van Belkum A., van Soolingen D. |
| |
|
Identification of SmrA, a novel efflux pump involved in fluoroquinolone resistance in Streptococcus suis
|
| Escudero J.A., San Millán A., Hidalgo L., Gutierrez B., Nieto S., Domínguez L., De la Campa A.G., González-Zorn B. |
| |
|
Identification of species in the Acinetobacter calcoaceticusA. baumannii complex isolated from blood cultures by an oligonucleotide assay
|
| Chang T-C., Su S-C., Lee N-Y., Dijkshoorn L., Ko W-C. |
| |
|
Identification of staphylococci by using commercial kits STAPHYtest 24 and API Staph
|
| Sedlacek I., Petras P., Pliskova Pakrova E., Skapova T., Jancova J., Jezek P., Machova I. |
| |
|
Identification of the pre-mRNA splicing protein U2AF35 in the opportunistic fungus Pneumocystis carinii
|
| Thomas C., Sanyal B., Vohra P. |
| |
|
Identification of the transmission vectors of Staphylococcus aureus circulating in a neonatal intensive care unit
|
| Conceicao T., Aires de Sousa M., Barroso R., Paulino E., Sancho L., Brito M., Garrote J., Carreiro H., Machado M., de Lencastre H. |
| |
|
Identification rate and susceptiblity of Candida isolates from blood cultures
|
| Dagwadordsch U., Dosa E., Doczi I., Wilhelms D., Nagy E., Kekulé A.S. |
| |
|
IL-17 is associated with severity of invasive meningococcal disease
|
| Beran O., Dzupova O., Lawrence D., Holub M. |
| |
|
Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors and impact of resistance on clinical outcomes in a Tunisian burn unit
|
| Thabet L., Bousselmi K., Messadi A. |
| |
|
Immigration and tuberculosis evolution in Catalonia central region. 10 years (19962005)
|
| Pina J., Ferrer A., Sala R.M. |
| |
|
Immunmodulatory potencies of linezolid in a LPS model of human whole blood
|
| Lambers C., Will M., Wagner C., Zeitlinger M. |
| |
|
Immuno-biochemical comparison of susceptible BALB/c and resistant C57BL/6 mice responses to Leishmania major infection
|
| Amini M., Nahrevanian H., Khatami S., Farahmand M., Javadian S., Fayaz S., Mirkhani F. |
| |
|
Immunological diagnosis of early Pseudomonas aeruginosa lung infection in cystic fibrosis patients
|
| Biffi A., Costantini D., Colombo C., Zazzeron L., Clarizia G., Garlaschi M.l., Cariani L. |
| |
|
Immunological evaluation of recombinant human serum albuminL7/L12 (Brucella abortus ribosomal protein) fusion protein in animal model
|
| Pakzad I., Rezaee A., Tabaraiee B., Rasaee M., Zavaran Hosseinee A. |
| |
|
Immunological evaluation of vi-vapsular polysaccharide of Salmonella typhi vaccine by serum bactericidal assay
|
| Ahmadi H., Tabaraiee B., Siadat S.D., Poor mirza gholi F., Norouzian D., Nejati M., Hedayati M.H., Mahmoodi K., Sharifat Salmani A., Abbasi M., Karbasian M., Adli Moghadam A. |
| |
|
Immunological issues in anti-meningococcal vaccination
|
| Goldblatt D. |
| |
|
Immunological responses to BCG vaccination in Mycobacterium bovis-challenged cattle
|
| Witchell J., Vordermeier M., Wangoo A., Goyal M. |
| |
|
Impact of Enterococcus ssp. on mortality and morbidity of patients with perforation of the small and large bowel. Retrospective analysis on 473 patients
|
| Kaffarnik M.F., Urban M., Utzolino S., Hopt U.T. |
| |
|
Impact of a new perioperative antibiotic prophylaxis policy on the antimicrobial resistance: experience in a comprehensive cancer centre
|
| Passerini R., Biffi R., Riggio D., Moretti L., Sandri M. |
| |
|
Impact of a positive Binax NOW Streptococcus pneumoniae urinary antigen test on antibiotics policy
|
| Matta M., Buu Hoï A., Varon E., Gutmann L., Mainardi J.L. |
| |
|
Impact of antibiotics on biofilm and some other properties of Klebsiella pneumoniae in vitro
|
| Hostacka A., Ciznar I. |
| |
|
Impact of highly active antiretroviral therapy and Candida spp. oral colonisation in AIDS patients in a Brazilian tertiary-care university hospital
|
| Delgado A.C., Aoki F.H., Colombo A., Pedro R.J., Resende M., Trabasso P., Oliveira M.S., Moretti M.L. |
| |
|
Impact of meticillin-resistance on the mortality in S. aureus VAP: a systematic review
|
| Athanassa Z., Siempos I., Falagas M. |
| |
|
Impact of PCV7 on invasive pneumococcal disease in Scotland
|
| Wilson J., Hill R., Eastaway A. |
| |
|
Impact of rapid identification of C. albicans and C. glabrata directly from blood cultures using PNA FISH technology on selection of antifungal therapy
|
| Della-Latta P., Whittier S., Wu F. |
| |
|
Impact of real-time polymerase chain reaction in the diagnosis of acute meningitis in children
|
| Tormo N., Latorrre J.C., Garcia T., Clari M.A., Navarro D., Gimeno C. |
| |
|
Impact of routine surgical and intensive care units admission surveillance cultures on hospital-wide nosocomial MRSA infections in a university hospital
|
| Chaberny I.F., Schwab F., Ziesing S., Suerbaum S., Gastmeier P. |
| |
|
Impact of skin and skin structure infections on hospital length of stay, mortality and costs: a matched cohort analysis
|
| Akhras K.S., Lin S., Quintana A., Hatoum H.T. |
| |
|
Impact of the interaction of R207910 with rifampicin on the treatment of murine tuberculosis
|
| Lounis N., Gevers T., Van Den Berg J., Andries K. |
| |
|
Impact of the new CLSI non-meningitis penicillin breakpoints on the reporting of antimicrobial susceptibility in pneumococcal infections
|
| Su L-H., Chiu C-H., Wu T-L., Kuo A-J., Sun C-F. |
| |
|
Implementation of an intravenous to oral switch policy for antimicrobials in a secondary care setting
|
| Dunn K., O'Reilly A., Treacy V., Rogers T., Bergin C. |
| |
|
Implementation of European breakpoints and the future of EUCAST
|
| Kahlmeter G. |
| |
|
Implementation of the "Do Bugs Need Drugs?" programme in British Columbia, Canada
|
| Blondel-Hill E.M., Dreher K., Patrick D., Carson M. |
| |
|
Implementing molecular detection of gastro-intestinal protozoa and implications for an algorithm for complete parasitological diagnostics in the microbiological laboratory routine
|
| Bruijnesteijn van Coppenraet L.E.S., Wallinga J.A., Ruijs G.J.H.M., Bruins M.J., Wolfhagen M.J.H.M., Verweij J.J. |
| |
|
Implication of Candida biofilm maturation on the susceptibility to amphotericin B, caspofungin and posaconazole, alone or in combination
|
| Tobudic S., Kratzer C., Graninger W., Lassnigg A., Vorderwinkler A., Fischer H., Presterl E. |
| |
|
Implication of basal core promoter/precore mutants upon genotype and clinical outcome in the hepatitis B virus
|
| Puche B., Palomares J.C., Nogales M.C., Figueruela B., Almeida C.V., Martin-Mazuelos E. |
| |
|
Implications of bacterial-viral interactions to present day pandemic preparedness the Spanish flu revisited
|
| Klugman K.P. |
| |
|
Importance of molecular detection for diagnosis and monitoring mumps-virus infection
|
| Royuela E., Castellanos A., Guisasola M.E., Sanz J.C., Mosquera M., Sanchez-Herrero C., De Ory Manchón F., Echevarría J.E. |
| |
|
Importance of pneumococcal bacteraemia for severity scoring in community-acquired pneumonia
|
| Strålin K., Holmberg H. |
| |
|
Improved long-term survival among AIDS patients with progressive multifocal leukoencephalopathy receiving potent antiretroviral therapies
|
| Garcia-Garcia J., Casado J.L., Corral I., Moreno A., Dronda F., Perez-Elias M.J., Peris J., Moreno S. |
| |
|
Improving diagnosis of Bordetella pertussis to improve patient management
|
| McCulloch E., Williams C. |
| |
|
Improving outbreak management by understanding barriers faced by professionals in hospitals and public health
|
| Timen A., Hulscher M., Vos D., van Steenbergen J., Grol R., van der Meer J. |
| |
|
Improving patient area disinfection cleaning in 34 acute care hospitals
|
| Carling P. |
| |
|
Improving the quality of care for community-acquired pneumonia using Web-based support for dissemination, communication and measurement
|
| Davey P.G., Leonard S., Patton A., Bucknall C. |
| |
|
In only half of the tuberculosis cases diagnosed in Zambia, Mycobacterium tuberculosis is the causative agent
|
| Buijtels P.C.A.M., Iseman M.D., Parkinson S., de Graaff C.S., Verbrugh H.A., Petit P.L.C., van Soolingen D. |
| |
|
In the bovine trichomoniasis experimental model, systemic immunisation, unlike preputial infection, induces protection against trichomonad colonisation in bulls
|
| Cobo E., Corbeil L., BonDurant R. |
| |
|
In vitro activities of several antimicrobials alone or in combination against MDR Acinetobacter baumannii isolated from intensive care unit
|
| López-Fabal F., González-Romo F., Culebras E., Picazo J.J. |
| |
|
In vitro activities of tigecycline against Aeromonas, Vibrio, and Salmonella species, Taiwan
|
| Huang Y-T., Liao C-H., Liu C-Y., Hsueh P-R. |
| |
|
In vitro activity of a cecropin A-melittin antimicrobial peptide hybrid vs. multidrug-resistant strains of Acinetobacter baumannii prevalent in the UK
|
| Wareham D., Khanna P., Kamysz W. |
| |
|
In vitro activity of a mixture of mustard oils (isothiocyanates) against antimicrobial and multidrug-resistant bacteria
|
| Conrad A., Bauer D., Nobis T., Richter H., Engels I., Jonas D., Frank U. |
| |
|
In vitro activity of anidulafungin combined with amphotericin B or fluconazole against Candida parapsilosis
|
| Eraso E., Marcos-Arias C., Carrillo-Muñoz A.J., Pontón J., Quindós G. |
| |
|
In vitro activity of caspofungin and anidulafungin against Candida albicans and C. glabrata biofilms
|
| Valentín A., Cantón E., Pemán J., Bosch M., Gobernado M., Martínez J.P. |
| |
|
In vitro activity of ceftobiprole against select Gram-positive and Gram-negative pathogens isolated from Europe in 20062007
|
| Torres M., Draghi D., Brown N., Thornsberry C., Sahm D., Pillar C. |
| |
|
In vitro activity of daptomycin against vancomycin-resistant Enterococci in patients with bacteraemia
|
| Xanthaki A., Tsiringa A., Skandami-Epitropaki V., Trelogianni X., Dimitriou V., Fotiou P., Toutouza M. |
| |
|
In vitro activity of daptomycin against various VanA VRE species derived from clinical specimens
|
| Stylianakis A., Tsiplakou S., Papaioannou V., Paraskevopoulou D., Pantazis E., Sardiniari S., Koutsoukou A. |
| |
|
In vitro activity of doripenem relative to meropenem and imipenem against Enterobacteriaceae and P. aeruginosa isolates from Europe (20062007)
|
| Torres M., Draghi D., Brown N., Thornsberry C., Sahm D., Pillar C. |
| |
|
In vitro activity of fosfomycin vs. extended-spectrum b-lactamase
|
| Amin A., Khanna P., O'Sullivan C., Wareham D. |
| |
|
In vitro activity of gallium against meticillin-susceptible and meticillin-resistant Staphylococcus aureus and S. epidermidis
|
| Baldoni D., Steinhuber A., Zimmerli W., Trampuz A. |
| |
|
In vitro activity of mecillinam in combination with aminopenicillin/b-lactamase-inhibitor Combinations against ESBL-producing Enterobacteriaceae
|
| Herbich K., Zeitlberger E., Stadler M., Janata O., Asboth F., Apfalter P. |
| |
|
In vitro activity of micafungin combined with amphotericin B or fluconazole against Candida parapsilosis
|
| Marcos-Arias C., Eraso E., Carrillo-Muñoz A.J., Pontón J., Quindós G. |
| |
|
In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin
|
| Woodford N., Afzal-Shah M., Warner M., Livermore D. |
| |
|
In vitro activity of temocillin vs. extended-spectrum b-lactamase-producing Enterobacteriaceae from the UK
|
| Khanna P., Wareham D. |
| |
|
In vitro activity of tigecycline against Acinetobacter baumannii tested by time-kill studies
|
| Aracil B., Gil Y., Gómez-Garcés J.L. |
| |
|
In vitro activity of tigecycline against Stenotrophomonas maltophilia tested by time-kill studies
|
| Aracil B., Gil Y., Gómez-Garcés J.L. |
| |
|
In vitro activity of tigecycline against contemporary clinical isolates of Streptococcus pneumoniae
|
| Blondeau J., Borsos S. |
| |
|
In vitro activity of tigecycline against enterococci
|
| Lesenne A., Aires J., Bourgeois-Nicolaos N., Couzon B., Doucet-Populaire F. |
| |
|
In vitro activity of tigecycline against inpatient and outpatient isolates from a European population
|
| Hackel M., Bouchillon S., Johnson B., Badal R., Johnson J., Hoban D., Dowzicky M. |
| |
|
In vitro activity of tigecycline against MRSA, vancomycin-resistant enterococci, and extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates collected in the Czech Republic
|
| Zemlickova H., Urbaskova P. |
| |
|
In vitro activity of tigecycline against multidrug-resistant Gram-negative clinical isolates
|
| Zarkotou O., Kopsari K., Korou E., Tsimettas J., Mantzouratou P., Gianneli D., Poulopoulou C. |
| |
|
In vitro activity of tigecycline against pathogens isolated from lower respiratory infections The Global T.E.S.T. Program 2007
|
| Hackel M., Badal R., Bouchillon S., Johnson J., Hoban D., Johnson B., Dowzicky M. |
| |
|
In vitro activity of tigecycline and 13 comparators against pathogens from a global population of intensive care patients in 2007
|
| Hackel M., Hoban D., Bouchillon S., Johnson B., Badal R., Johnson J., Dowzicky M. |
| |
|
In vitro activity of tigecycline and comparators against vancomycin-resistant enterococci from western Europe
|
| Badal R., Johnson B., Bouchillon S., Hackel M., Johnson J., Hoban D., Dowzicky M. |
| |
|
In vitro activity of tigecycline and other antimicrobial drugs against selected pathogens isolated in Mexico
|
| Ponce de Leon A., Amabile-Cuevas C.F., Benitez A. |
| |
|
In vitro activity of tigecycline tested against pneumonia pathogens from patients hospitalised in European medical centres, including multidrug-resistant Acinetobacter spp.
|
| Sader H., Jones R., Janechek M., Fritsche T. |
| |
|
In vitro activity profile of oritavancin against resistant staphylococcal populations from a recent surveillance initiative in Europe
|
| Sahm D., Moeck G., Pillar C., Arhin F., Draghi D. |
| |
|
In vitro adsorption and release of antibiotics from cancellous bone
|
| Sahinides T., Kanellakopoulou K., Galanakis N., Chrisouli Z., Giamarellou H. |
| |
|
In vitro and in vivo activity of SB006, a novel branched antimicrobial peptide selectively active against Gram-negative bacteria.
|
| Fabiole Nicoletto S., Baster I., Pirri G., Giuliani A. |
| |
|
In vitro anti-biofilm activity of micafungin in a lock strategy
|
| Cateau E., Rodier M-H., Berjeaud J-M., Imbert C. |
| |
|
In vitro bactericidal effect of imipenem, meropenem and piperacillin/tazobactam against b-lactam-resistant Pseudomonas aeruginosa strains and ESBL-producing Enterobacteriaceae
|
| Muller-Serieys C., Merens A., Cavallo J.D., Laussucq C., Joly-Guillou M.L., Roussel-Delvallez M. |
| |
|
In vitro effect of fusidic acid on staphylococcus strains with macrolide-lincosamid-streptogramin B resistance
|
| Sesli Cetin E., Gunes H., Aynali A., Kaya S., Cicioglu Aridogan B., Demirci M. |
| |
|
In vitro enrichment of resistant Staphylococcus aureus at daptomycin subtherapeutic concentrations within the mutant selection window: effect of treatment duration
|
| Vostrov S., Lubenko I., Zinner S., Firsov A. |
| |
|
In vitro evaluation of tigecycline against drug-resistant Enterococci and S. aureus in the United States
|
| Johnson J., Hoban D., Johnson B., Bouchillon S., Stevens T., Dowzicky M. |
| |
|
In vitro investigation of the intercellular cross-talk between opportunistic bacteria and eukaryotic cells
|
| Bleotu C., Balotescu Chifiriuc M., Iordache C., Dracea O., Bucur M., Larion C., Matei L., Banu O., Cernat R., Lazar V. |
| |
|
In vitro post antibiotic effect of isavuconazole, voriconazole and amphotericin B against a strain of C. albicans with concentration-dependent pharmacokinetics in a murine model and susceptibility of strains for murine kidneys post infection
|
| Warn P.A., Sharp A., Majithiya J.B., Parmar A., Denning D.W. |
| |
|
In vitro selected mutants of M. tuberculosis do not reflect the in vivo mechanism of isoniazid resistance
|
| Bergval I., Schuitema A., Klatser P., Anthony R. |
| |
|
In vitro selection of probiotic multispecies against Clostridium difficile 027
|
| Veenendaal D., Dijkstra M., Timmerman H. |
| |
|
In vitro selection of resistance by in vivo concentrations of fluoroquinolones in Pseudomonas aeruginosa and Staphylococcus aureus
|
| Drago L., Nicola L., Zanini S., De Vecchi E. |
| |
|
In vitro susceptibilities of clinical isolates of filamentous fungi to new antifungal agents
|
| Linares M.J., Solís F., Casal M. |
| |
|
In vitro susceptibility of Candida species isolated from blood to common antifungal agents in a Spanish tertiary medical centre
|
| Alkorta M., Hernandez-Almaraz J., Eraso E., Quindós G. |
| |
|
In vitro susceptibility of Candida species to micafungin: a comparison of methods
|
| Gray V.L., Duddy N.E., Harris S., Howard S.J., Denning D.W., Moore C.B. |
| |
|
In vitro susceptibility of clinical isolates of Candida kefyr
|
| Gomez-Lopez A., Pan D., Rodriguez-Tudela J.L., Cuenca-Estrella M. |
| |
|
In vitro susceptibility of clinical isolates of Dipodascus capitatus
|
| Cendejas E., Gómez-López A., Cuenca-Estrella M., Rodríguez-Tudela J. |
| |
|
In vitro susceptibility of group B Streptococcus strains isolated from genital tract of pregnant women
|
| Bosch J., Guardià C., Juncosa T., Andreu A., Lite J., Sanfeliu I. |
| |
|
In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes in a twelve-month period
|
| Popescu G.A., Benea E., Popescu C., Popoiu M., Furtuna M., Antonica D., Ivan M., Botea S., Streinu-Cercel A. |
| |
|
In vitro susceptibility patterns to 13 antimicrobials against Pseudomonas aeruginosa cystic fibrosis patients in the UK
|
| Khanna P., Soleimanian S., Wareham D. |
| |
|
In vitro susceptibility testing of fungal isolates from immunosuppressed, organ-transplanted patients for anidulafungin and azoles
|
| Antoniewicz L., Poitschek C., Willinger B., Geusau A. |
| |
|
In vitro testing of carbapenem-resistant Acinetobacter baumannii to colistin (polymyxin E)
|
| Goic-Barisic I., Bedenic B., Tonkic M., Novak A., Punda-Polic V. |
| |
|
In vitro time-kill studies of oritavancin against drug-resistant isolates of Staphylococcus aureus
|
| McKay G.A., Beaulieu S., Arhin F.F., Parr Jr. T.R., Moeck G. |
| |
|
In vitro-activity of tigecycline and daptomycin against vancomycin-resistant enterococci and meticillin-resistant staphylococci
|
| Tsiringa A., Skandami-Epitropaki B., Xanthaki A., Arida P., Marounga E., Toutouza M. |
| |
|
In vivo bactericidal effect of a new proline-rich peptide A3-APO on an ESBL-producing Escherichia coli strain
|
| Rozgonyi F., Nagy K., Szabó D., Anderlik P., Kocsis B., Ötvös L. |
| |
|
In vivo effectiveness and dose response of BAL30376 in murine peritonitis sepsis model caused by Pseudomonas aeruginosa or by extended-spectrum b-lactamase producing Escherichia coli
|
| Navon-Venezia S., Page M., Schmitt-Hoffmann A., Carmeli Y. |
| |
|
In vivo efficacy of moxifloxacin monotherapy against clinical isolates of B. fragilis with intermediate susceptibility
|
| Glenschek-Sieberth M., Merfort K., Obertegger S., Kne[zcaron]evic I., Endermann R. |
| |
|
In vivo fluoroquinolone concentrations and in vitro selection of resistance in Streptococcus pneumoniae
|
| De Vecchi E., Nicola L., Zanini S., Drago L. |
| |
|
In vivo selection of carbapenem resistance in Acinetobacter baumannii mediated by ISAba1 mobilisation upstream of the blaOXA-51 natural oxacillinase gene
|
| Figueiredo S., Poirel L., Croize J., Recule C., Nordmann P. |
| |
|
In vivo selection of carbapenem-resistant Pseudomonas aeruginosa following sub-optimal dosing
|
| Tam V.H., Ledesma K.R., Schilling A.N., Chang K.T., Lim T.P., Ghose R., Lewis R.E. |
| |
|
In vivo transposition of insertion sequence ISAba1 at the origin of genome plasticity and acquired antibiotic resistance in Acinetobacter baumannii
|
| Poirel L., Mugnier P., Nordmann P. |
| |
|
Incidence and predictors of nevirapine-associated rash in experienced HIV patients who switched from other antiretroviral regimens to nevirapine-based regimen
|
| Putcharoen O., Satitthummanid S., Avihingsanon A. |
| |
|
Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus
|
| Jeong S.J., Choi H.K., Lee H.S., Chin B.S., Choi S.H., Han S.H., Kim M.S., Kim C.O., Choi J.Y., Song Y.G., Choe K.W., Kang M.W., Kim J.M. |
| |
|
Incidence and risk factors of recurrent bacteraemia due to Escherichia coli
|
| Villar J., Rodriguez Aranda A., Sanz F., Otero J.R., Chaves F. |
| |
|
Incidence of candidaemia: 5-year results from emerging infections in patients from the intensive care unit of a tertiary hospital
|
| Cortizo-Vidal S., Santiago I., Villamil-Cajoto I., Rodriguez-Otero L., Martinez-Lamas L., Aguilera-Guirao A., García-Riestra C., García-Zaabarte Á. |
| |
|
Incidence of central venous catheter-related infection in a community hospital
|
| Delgado M., Yebenes J., Ballester L., Sauca G., Vidal E., Icart R., Capdevila J. |
| |
|
Incidence of human papillomavirus genotypes and estimated repercussion of quadrivalent vaccine in Cadiz, Spain
|
| Cebada M., Blanco M., Popa I., Lozano A., Reyes M., Fernández C. |
| |
|
Incidence of newer antifungal consumption and incidence of Candidaemia in an adult intensive care unit
|
| Garbino J., Vernaz N., Peant C., Bouchuiguir-Wafa K., Rohner P., Romand J. |
| |
|
Incidence of syphilis in a cohort of HIV-infected subjects, Italy
|
| Matteelli A., Basché R., Carvalho A., Cristini G., Paraninfo G., Caligaris S., Capone S., Castelnuovo F., El Hamad I., Carosi G. |
| |
|
Increase of resistance to glycopeptides and epidemiological changes among nosocomial enterococci detected during 2007 in a Portuguese hospital
|
| Almeida F., Fernándes F., Carvalho S., Ferreira T., Mato R. |
| |
|
Increased antimicrobial susceptibility profiles among polymyxin-B-resistant Acinetobacter baumannii clinical isolates
|
| Mendes R., Fritsche T., Sader H., Jones R. |
| |
|
Increased expression of Werner and Bloom helicases in peripheral blood mononuclear cells of HIV-1 infected patients
|
| Amendola A., Bordi L., D'Offizi G., Vlassi C., Lalle E., Nardacci R., Capobianchi M. |
| |
|
Increased fluoroquinolone resistance co-selected with improved bacterial fitness
|
| Hughes D., Marcusson L. |
| |
|
Increased mutation frequency among Enterococcus faecium belonging to clonal complex 17
|
| Ruiz-Garbajosa P., Top J., Coque T.M., Cantón R., Bonten M.J., Baquero F., Willems R.J. |
| |
|
Increasing incidence of extrapulmonary tuberculosis but stable rates of resistance of Mycobacterium tuberculosis isolates to first-line anti-tubercular drugs in Kuwait, 19962005
|
| Mokaddas E., Ahmad S., Samir I. |
| |
|
Increasing number of ESBL-producing Escherichia coli during the last three years in Stockholm A challenge for the clinical laboratory
|
| Iversen A., Andersson M., Vondracek M., Giske C.G. |
| |
|
Increasing numbers of Rhodococcus infections at a large university hospital NHS Trust, Nottingham An investigation
|
| Capewell S., Palfreyman J. |
| |
|
Increasing use of immunosuppression and biological therapies: the establishment of a designated clinic to prevent infectious complications
|
| Mac Nicholas R., Ahmed S.E., Hamed M., De Barra E., El Shariff O., Bergin C., Norris S., Keeling P.W.N., Mahmud N. |
| |
|
Independent emergence of quinolone resistance in CTX-M-5 b-lactamase-producing isolates of Salmonella typhimurium from Russia, Belarus and Kazakhstan
|
| Kozyreva V., Tapalski D., Azizov I., Edelstein M. |
| |
|
Indigenous amebiasis in hypoendemic area: myth or reality?
|
| Ivanova M., Nedzvedz M., Poljakova S., Saridze E., Fedorovich S., Glod E. |
| |
|
Induction of apoptosis by the triterpene saponin PX-6518 in promastigotes and amastigotes of Leishmania infantum
|
| Vermeersch M., Deschacht M., Kuypers K., Schrijvers D., Martinet W., Cos P., Maes L. |
| |
|
Induction of telithromycin resistance by several macrolide antibiotics in Enterococcus spp. and Streptococcus spp.
|
| Perez J., Culebras E., Gomez M., Picazo J. |
| |
|
Infection as an initiation of coagulation and inflammation: targeting the lung
|
| van der Poll T. |
| |
|
Infections after cardiac surgery
|
| Ezpeleta C., Alava J.A., Gómez E., Busto C., Atutxa I., Unzaga J., Cisterna R. |
| |
|
Infections and other problems on ferries and cruise ships
|
| Dahl E. |
| |
|
Infections due to antibiotic-resistant bacteria diagnosed at hospital admission. Incidence and risk factors
|
| Tacconelli E., Iannotti N., Venturiello S., Cataldo M., Muscatello A., Spanu T., Fadda G., Cauda R. |
| |
|
Infections in patients with head injury: a 6-year retrospective study
|
| Kourbeti I., Papadakis J., Karabetsos D., Neophytou C., Filippou M., Ioannou A., Anastasaki M., Vakis A. |
| |
|
Infections in patients with myelodysplastic syndromes
|
| Kofteridis D.P., Stavroulaki A., Valachis A., Kalpadaki C., Tzanakakis M., Papadaki H.A., Samonis G. |
| |
|
Infectious complications of short-term ventricular assist devices
|
| Muñoz P., Padilla C., Barrio J.M., Ruiz M., Yañez J., Bouza E. |
| |
|
Infective endocarditis in children: a single cohort study of 51 cases in a French university hospital
|
| Abouchraa A., Zahar J.R., Carbonnelle E., Bajolle F., Ribadeau-Dumas F., Mechai F., Offredo C., Sidi D., Lortholary O. |
| |
|
Inflammatory cell infiltration and inflammatory cytokines: indicators of Streptococcus agalactiae infection in experimental mouse mastitis
|
| Trigo G., França A., Dinis M., Gil da Costa R., Bonifácio Andrade E., Ferreira P., Tavares D. |
| |
|
Influence of a hygiene promotion programme in infection control on an intensive care unit
|
| Murcia-Payá J.F., García-Vázquez E., Melgarejo-Moreno A., Martínez-Hernández J., Gil-Sánchez F.J., Canteras M., Gómez-Gómez J., Allegue J. |
| |
|
Influence of anidulafungin on different Candida species in a continuous flow culture system
|
| Bernhardt H., Knoke M., Schwesinger G., Gloeckner A., Bufler J., Czaika V., Ludwig K., Bernhardt J. |
| |
|
Influence of antibiotics during delivery work on early onset sepsis
|
| Aguilar A., Juncosa T., Gené A., Iriondo M., Alarcón A., Thió M. |
| |
|
Influence of anti-retroviral treatment on gastric secretion, Helicobacter pylori colonisation of gastric mucosa and fungal colonisation of upper gastrointestinal tract in HIV-infected patients
|
| Skwara P., Ciesla A., Sobczyk-Krupiarz I., Bociaga M., Kalinowska-Nowak A., Mach T. |
| |
|
Influence of climatic factors on tick-borne encephalitis incidence in the Czech Republic
|
| Daniel M., Kriz B., Danielová V., Valter J., Kott I. |
| |
|
Influence of combined contraceptive vaginal ring on vaginal microflora and immunity
|
| Orlova V., Naberezhnev Y., Lebedeva O. |
| |
|
Influence of linezolid on phagocytosis and killing of Gram-negative bacteria by polymorphonuclear neutrophils
|
| Grüger T., Schnitzler N., Nidermajer S., Brandenburg K., Zündorf J. |
| |
|
Influence of liposomal amphotericin B on the renal function of intensive care patients with elevated serum creatinine levels. A multicentre, retrospective, observational case collection study
|
| Alvarez-Lerma F., Mariscal F., Nieto M., Pérez M., Pinilla C., Puente T., Ausín I. |
| |
|
Influence of local and global regulators on efflux-mediated resistance of Salmonella enteritidis: contributions to a pleiotropic phenotype
|
| O'Regan E., Quinn T., Fanning S. |
| |
|
Influence of p38 MAPK isoforms (alpha, beta, gamma and delta) in apoptosis induced by HIV-1 in CD4+ T lymphocyte-based cell lines
|
| Gutierrez-Sanmartin D., Varela-Ledo E., Aguilera-Guirao A., Romero-Yuste S., Romero-Jung P., Gomez-Tato A., Regueiro B.J. |
| |
|
Influence of PCR parameters on the prevalence of Panton-Valentine leukocidin positivity in Staphylococcus aureus isolates
|
| Karahan Z.C., Dolapci I., Tekeli A. |
| |
|
Influence of rapid antigen detection test use to antibiotic prescribing for tonsillopharyngitis
|
| Berzanskyte A., Valinteliene R., Palekauskaite A. |
| |
|
Influence of the method for detecting reduced vancomycin susceptibility in meticillin-resistant Staphylococcus aureus bacteraemia. A 14-year study
|
| Camarena J.J., Gonzalez R., Nogueira J.M., Zaragoza R., Andrade P., Quintero V. |
| |
|
Influence of thymidine on bactericidal activity of iclaprim against vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus strains
|
| Pankuch G., Appelbaum P. |
| |
|
Influenza virus vaccination in kidney transplant patients: serum antibody response to different immunosuppressive drugs
|
| Salles M.J.C., Sens Y.A.S., Machado C.M., Boas L.V. |
| |
|
Information overload or under load! How national knowledge weeks can help busy professionals
|
| Wiseman S., Hansraj F., Kostkova P., Jawaheer G., Catchpole M., Roy A., Freed J. |
| |
|
Inhaled corticosteroids increase the risk of pneumonia? A further step in a population-based study
|
| Almirall J., Bolibar I., Serra-Prat M., Roig J., Hospital I., Carandell E., Agustí M., Ayuso P., Balanzó X., Torres A. |
| |
|
Inhibitory effect of hyperimmune LPS antiserum in attachment of E. coli O157:H7 to HEP-2 cell and murine model
|
| Moradi Bidhendi S., Khaki P., Pourbakhsh S., Sattari M., Heidari M. |
| |
|
Innate immunomodulating therapies
|
| Calandra T. |
| |
|
Inoculum effect of b-lactams and killing curves determination in AmpC-producing (DHA-1) Klebsiella pneumoniae isolates
|
| Cerna H., Bergerova T., Urbaskova P., Hrabak J. |
| |
|
Integrated international molecular databases in monitoring the emergence and spread of infection
|
| Dallman T.J., Green J., Gnaneshan S., Myers R. |
| |
|
Interaction of PZ-601 (SMP-601) and other b-lactams with chromosome- and plasmid-encoded class C b-lactamases
|
| Docquier J.D., Xerri L. |
| |
|
Interactions between serotype and mutations in quinolone-resistance determining regions of Streptococcus pneumoniae
|
| Melano R., McGeer A., Drews S., Pong-Porter S., Gubbay J., Seah C., Higgins R., Tyrrell G., Green K., Low D.E. |
| |
|
Interest of a new technique of DNA chips for detection of respiratory viruses
|
| Causse M., Garcia A., Gutierrez J., Casal M. |
| |
|
Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium
|
| Nairz M., Fritsche G., Mair S., Theurl M., Theurl I., Schroll A., Brunner P., Hantke K., Weiss G. |
| |
|
International Circumpolar Surveillance of invasive bacterial diseases, 20002006
|
| Zulz T., Bruce M.G., Parks D., Tam T., Stenz F., Nystedt A., Lovell O., Parkinson A.J. |
| |
|
International dissemination of a multi-resistant IncA/C2 plasmid containing blaTEM-24, Tn21 and Tn1696 among epidemic and non-epidemic Enterobacteriaceae species
|
| Novais A., Cantón R., Machado E., Curiao T., Baquero F., Peixe L., Coque T.M. |
| |
|
International external quality assessment programme for the molecular detection of Legionella pneumophila in respiratory samples: results from 2006 and 2007
|
| De Mendonça R., MacKay W.G., Wallace P.S., Rottiers S., Crevecoeur S., Struelens M.J., van Loon A.M. |
| |
|
Interrelation between typhoid fever process and monocytes with expression of C3bR receptor
|
| Tuychiev J., Aripov S. |
| |
|
Intestinal Oxalobacter formigenes colonisation in children with calcium oxalate urolithiasis. A study from southeastern Poland.
|
| Sikora P., Niedzwiadek J., Mazur E., Niedzwiadek A., Zajaczkowska M., Koziol-Montewka M. |
| |
|
Intra- and extracellular activity of dicloxacillin and linezolid against small colony variants of Staphylococcus aureus in vivo
|
| Sandberg A., Hughes D., von Eiff C., Skov R.L., Frimodt-Møller N. |
| |
|
Intra-catheter leukocyte stain and culture as a diagnostic tool in an experimental animal model of port-related bloodstream infection
|
| Serrera A., Martinez A., Alonso M., Guillen-Grima F., Aguinaga A., Gonzalez R., Leiva J., del Pozo J.L. |
| |
|
Intracellular activity of antibiotics against Staphylococcus aureus internalised human skin keratinocytes: comparison with THP-1 macrophages
|
| Lemaire S., Van Bambeke F., Pirnay J.P., Verween G., De Corte P., De Vos D., Tulkens P.M. |
| |
|
Intracellular activity of antibiotics against a stable small colony variant of Staphylococcus aureus isolated from a CF patient in model Calu-3 human airway epithelial cells
|
| Nguyen H.A., Denis O., Vergison A., Tulkens P.M., Struelens M.J., Van Bambeke F. |
| |
|
Intracellular crystallisation caused by Proteus mirabilis plays a significant role in recurrent urolithiasis
|
| Torzewska A., Budzynska A., Bialczak-Kokot M., Rozalski A. |
| |
|
Intracellular penetration and activity of the new fluoroquinolone UB-8902 in human polymorphonuclear leukocytes
|
| Ballesta S., García I., Sánchez-Céspedez J., Vila J., Pascual A. |
| |
|
Intrafamilial spread of Panton-Valentine-positive Staphylococcus aureus: a Spanish case
|
| Gutiérrez-González I., Batista-Díaz N., Pérez-Roth E., Hernández-de la Torre M., Durán-Trujillo M., Delgado-Guerrero M., Méndez-Álvarez S. |
| |
|
Intrapartum screening of group B Streptococcus using GeneXpert real-time PCR versus late antenatal screening by culture
|
| El Helali N., Ly A., Nguyen J.C., Giovangrandi Y., Sauvanet E. |
| |
|
Intrinsic drug resistance of M. aviumM. intracellulare complex: the role played by efflux pumps
|
| Rodrigues L., Wagner D., Viveiros M., Sampaio D., Martins M., Couto I., Vavra M., Kern W., Amaral L. |
| |
|
Invasive Staphylococcus aureus Infections Cohort (INSTINCT)
|
| Wisplinghoff H., Kaasch A., Achilles K., Langhorst A., Peyerl-Hoffmann G., Wöhrmann A., Fätkenheuer G., Salzberger B., Kern W., Seifert H. |
| |
|
Invasive aspergillosis in haematological patients by exposure to laminar air flow: description of 65 cases between 2004 and 2006
|
| Nicolle M.C., Thiebaut A., De Monbrison F., Voirin N., Thomas X., Nicolini F.E., Perraud M., Picot S., Vanhems P., Michallet M. |
| |
|
Invasive candidiasis, Candida colonisation and antifungal treatment in intensive care patients after cardiothoracic surgery
|
| Kratzer C., Tobudic S., Graninger W., Lassnigg A., Vorderwinkler A., Fischer H., Presterl E. |
| |
|
Invasive pneumococcal disease in children after introduction of pneumococcal conjugate vaccine
|
| Cendejas E., Romero M., Baquero F., Gomez-Gil R., Gutierrez A. |
| |
|
Investigation of affinity properties of receptor protein G of group G streptococci in different flow-through models using the approaches of affinity high-performance monolithic disk chromatography
|
| Lozhkina O., Gupalova T., Totolian A., Tennikova T. |
| |
|
Investigation of an outbreak of Stenotrophomonas maltophilia bacteraemia in an haemato-oncology unit: unexpected genetic diversity of isolates
|
| Nahimana Tessemo I., Senn L., Bellini C., Blanc D.S., Zanetti G. |
| |
|
Investigation of epidemiological links between patients harbouring identical, non-predominant MRSA genotypes as defined by double-locus sequence typing
|
| Senn L., Zanetti G., Bally F., Chuard C., Cometta A., Eisenring M.C., Kuhn G., Blanc D.S. |
| |
|
Investigation of imipenem efficacy against carbapenem-susceptible but heteroresistant Acinetobacter baumannii clinical isolates by experimental pneumonia
|
| Michail G., Ikonomidis A., Neou E., Maniatis A., Pournaras S. |
| |
|
Investigation of mutations in ERG11 gene of fluconazole-resistant Candida albicans isolates from Turkish hospitals
|
| Manastir L., Ergon C., Yucesoy M. |
| |
|
Investigation of role of IS elements in conversion to hypermutability and emergence of drug resistance in Pseudomonas aeruginosa from CF patients in Cape Town, South Africa
|
| Evans J.C., Motilal N., Segal H. |
| |
|
Investigation of the genetic basis of erythromycin resistance in Staphylococcus aureus, including MRSA, from Pakistan
|
| Ullah F., Malik S.A., Ahmed J., Snelling A.M. |
| |
|
Investigation of vancomycin-resistant enterococci faecal carriage in intensive care units of a Turkish teaching hospital in a two-year period
|
| Iris N., Sayiner H., Simsek F., Arat M., Yildirmak T. |
| |
|
Investigation of viral infections in kidney transplant recipients unveils the pathogenic role of Parvovirus B19 in chronic allograft injury
|
| Barzon L., Pacenti M., Biasolo M., Murer L., Palù G. |
| |
|
Investigative use only test card using the VITEK 2 system as compared to broth microdilution
|
| Buckner R., Fuller D., Davis T., Newcomer K., Mirrett S., Reller L., Smith-Moland E. |
| |
|
Iron overload favours the elimination of Leishmania infantum from mouse tissues by enhancing the production of reactive oxygen species
|
| Costa S., Pereira S., Teixeira C., Tomás A., Appelberg R., Gomes S. |
| |
|
Is Bartonella bacilliformis, endemic pathogen of the Andean areas, intrinsically resistant to quinolones?
|
| Ruiz J., Flores L., Vargas M., Garcia de la Guardia R., Quispe R., Ibañez Z.B., Alvarado D., Ramirez P., del Valle L.J. |
| |
|
Is Helicobacter pylori the only aetiologic factor involved in the pathogenesis of gastric cancer among Iranian population?
|
| Mohajerani N., Talebkhan Y., Esmaeili M., Bababeik M., Oghalaie A., Nahvijoo A., Eshagh Hosseini M., Mohagheghi M.A., Abdirad A., Mohammadi M. |
| |
|
Is cotrimoxazole prophylaxis still reliable for the prevention of nocardiosis?
|
| Muñoz P., Marin M., Valerio M., Cercenado E., Guinea J., Martín-Rabadán P., Radice C., Fernández-Cruz A., Bouza E. |
| |
|
Is interferon-gamma TB-testing in accordance with guidelines
|
| Meyer C.N., Browatzki A. |
| |
|
Is it time for pan-European surveillance of healthcare-related infections?
|
| Gastmeier P. |
| |
|
Is multiple-stool-specimen ova and parasite examination necessary?
|
| Grünbaum F., Muñoz C., Morató R., Giménez E., Soler R., Llobet T., Coll P. |
| |
|
Is screening for colonisation of extended-spectrum b-lactamase producing Klebsiella pneumoniae in intensive care unit necessary in the absence of an outbreak?
|
| Metan G., Ozkuyumcu C., Koseoglu Eser O., Topeli Iskit A., Hascelik G., Unal S. |
| |
|
Is the case for antifungal prophylaxis in the ICU now established beyong doubt? PRO
|
| Eggimann P. |
| |
|
Is the emergency department the place to be for optimum Clostridium difficile-associated disease control?
|
| Dhondt E., Cossey V., Schuermans A., Duerinckx R., Knockaert D. |
| |
|
Is there a place for the military in contributing to a global programme managing the MDR-TB challenge and beyond?
|
| Dhondt E., Peeters T., Laire G. |
| |
|
Is there any difference between non-smoker and smoker tuberculous patients in clinical manifestations and radiographic findings?
|
| Sharifi-Mood B., Metanat M. |
| |
|
Is trimethoprim adequate as first-line empirical treatment for urinary tract infection?
|
| Gallos I., Yee L., Diakos E. |
| |
|
Is vancomicin necessary in empirical treatment of community-acquired meningitis?
|
| Güerri R., Vallecillo G., Sánchez F., Lerma E., Solé E., Villar J., López-Colomés J.L., Perello R., Díez-Pérez A. |
| |
|
Is venous access port inner surface colonisation related with port obstruction?
|
| Alonso M., Martinez A., Serrera A., Ramos A., Bilbao J.I., Portillo M., Leiva J., del Pozo J.L. |
| |
|
IS257 and heterogeneous location of ileS2 gene in high-level mupirocin resistance staphylococcal plasmids
|
| Pérez Roth E., Alcoba Florez J., Laich F., Méndez Álvarez S. |
| |
|
ISEcp1-mediated transposition of qnrB5 gene in Escherichia coli
|
| Cattoir V., Poirel L., Silva J., Espinal P., Soussy C., Nordmann P. |
| |
|
Isolated renal hydatid cyst in a child: case report and review on renal hydatidosis
|
| Metanat M., Sharifi-Mood B., Pejman B., Ahmadi R. |
| |
|
Isolation from blood cultures and susceptibility testing of Candida sp. strains during three years in a tertiary hospital in Greece
|
| Orfanidou M., Ganteris G., Karanika M., Ziva K., Petropoulou D., Malamou-Lada H. |
| |
|
Isolation of Asaia sp. in two bacteraemia cases in patients with idiopathic dilated cardiomyopathy awaiting heart transplants
|
| Juretschko S., Beavers-May T., Helsel L., Steigerwalt A., Stovall S. |
| |
|
Isolation of carbapenemase-producing Pseudomonas otitidis from a patient with chronic otitis media
|
| Lee K., Kim C.K., Yong D., Yum J.H., Chung M.H., Chong Y., Thaller M.C., Rossolini G.M. |
| |
|
Isolation of late-stage Plasmodium falciparum infected red blood cells using a new cost- and time-saving magnetic cell separation kit
|
| Bhakdi S.C., Hartmann A., Sratogno P., Chuncharunee A., Neumann H.P., Malasit P., Pattanapanyasat K. |
| |
|
Isolation of sulfate reducing bacteria from dental unit waterlines
|
| Dogruoz N., Ilhan-sungur E., Goksay D., Türetgen I., Cotuk A. |
| |
|
It takes two to tango bacterial-viral interactions in the pathogenesis of respiratory tract infections
|
| McCullers J. |
| |
|
Itraconazole-ciprofloxacin interaction on the pharmacokinetics of the intestinal compartment: preliminary results in rats
|
| Benini A., Caveiari C., Franceschetti P., Bertazzoni E. |
| |